首页|银杏叶提取物注射液联合双联抗血小板治疗急性脑梗死恢复期患者的效果

银杏叶提取物注射液联合双联抗血小板治疗急性脑梗死恢复期患者的效果

扫码查看
目的:银杏叶提取物注射液联合双联抗血小板治疗急性脑梗死(ACI)恢复期患者的效果.方法:回顾性分析 2021 年 2 月至2023年2月该院收治的94例ACI恢复期患者的临床资料,依据治疗方法不同将其分为对照组和观察组各47例.两组均给予降脂、抗感染、营养神经等常规治疗,在此基础上,对照组采用双联抗血小板治疗,观察组在对照组基础上联合银杏叶提取物注射液治疗.比较两组临床疗效,治疗前后美国国立卫生研究院卒中量表(NIHSS)评分、血清炎性因子[白细胞介素-6(IL-6)、纤维蛋白原(FIB)]水平、凝血功能指标[凝血酶时间(TT)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)]水平,以及不良反应发生率.结果:观察组治疗总有效率为 93.62%(44/47),对照组治疗总有效率为 82.98%(39/47),差异无统计学意义(P>0.05);观察组基本痊愈率为 29.79%(14/47),高于对照组的 12.77%(6/47),差异有统计学意义(P<0.05).治疗后,观察组血清FIB、hs-CRP、IL-6 水平均低于对照组,TT、PT、APTT值均高于对照组,差异有统计学意义(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:银杏叶提取物注射液联合双联抗血小板治疗ACI恢复期患者可提高临床疗效,减轻神经功能损伤,降低炎性因子水平,改善凝血功能,效果优于单纯双联抗血小板治疗.
Effects of Ginkgo biloba extract injection combined with dual antiplatelet therapy on patients with acute cerebral infarction in convalescent period
Objective:To observe the effect of Ginkgo biloba extract injection combined with dual antiplatelet therapy on patients with acute cerebral infarction(ACI)in convalescent period.Methods:The clinical data of 94 patients with ACI in convalescent period admitted to this hospital from February 2021 to February 2023 were retrospectively analyzed.According to different treatment methods,they were divided into control group and observation group,47 cases in each group.Both groups were given lipid-lowering,anti-infection,nerve nutrition and other conventional treatment.On this basis,the control group was treated with dual antiplatelet therapy,while the observation group was treated with Ginkgo biloba extract injection on the basis of that of the control group.The clinical efficacy,the National Institutes of Health stroke scale(NIHSS)score,the serum inflammatory factors[interleukin-6(IL-6),fibrinogen(FIB)]levels,the coagulation function indexes[thrombin time(TT),prothrombin time(PT),activated partial thromboplastin time(APTT),fibrinogen(FIB)]levels,and the incidence of adverse reactions were compared between the two groups before and after the treatment.Results:The total effective rate of the observation group was 93.62%(44/47),that of the control group was 82.98%(39/47),and the difference was not statistically significant(P>0.05).The basic cure rate of the observation group was 29.79%(14/47),which was higher than 12.77%(6/47)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of FIB,hs-CRP and IL-6 in the observation group were lower than those in the control group,the values of TT,PT and APTT were higher than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Ginkgo biloba extract injection combined with dual antiplatelet therapy can improve the clinical efficacy,reduce the neurological impairment,reduce the levels of inflammatory factors and improve the coagulation function in the patients with ACI in convalescent period.Moreover,it is superior to single dual antiplatelet therapy.

Acute cerebral infarctionConvalescent periodGinkgo biloba extractDual anti-plateletNeurological function

魏丽丽

展开 >

济源市第二人民医院内二科,河南 济源 459000

急性脑梗死 恢复期 银杏叶提取物 双联抗血小板 神经功能

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(5)
  • 12